Gainers
- Reshape Lifesciences (NASDAQ:RSLS) stock increased by 22.3% to $0.47 during Thursday's pre-market session. The market value of their outstanding shares is at $6.1 million.
- Esperion Therapeutics (NASDAQ:ESPR) shares rose 21.85% to $1.84. The company's market cap stands at $209.2 million.
- Femasys (NASDAQ:FEMY) stock increased by 20.98% to $0.92. The company's market cap stands at $19.8 million.
- Bio-Path Hldgs (NASDAQ:BPTH) stock moved upwards by 20.34% to $0.59. The market value of their outstanding shares is at $7.2 million.
- Codexis (NASDAQ:CDXS) stock moved upwards by 19.61% to $2.5. The company's market cap stands at $174.5 million.
- Akso Health Group (NASDAQ:AHG) stock rose 19.28% to $0.68. The market value of their outstanding shares is at $15.5 million.
Losers
- NextCure (NASDAQ:NXTC) shares fell 19.3% to $1.17 during Thursday's pre-market session. The market value of their outstanding shares is at $32.6 million.
- Apellis Pharmaceuticals (NASDAQ:APLS) shares declined by 14.13% to $54.0. The company's market cap stands at $6.3 billion.
- Ocular Therapeutix (NASDAQ:OCUL) stock fell 13.96% to $3.39. The market value of their outstanding shares is at $269.2 million.
- Pasithea Therapeutics (NASDAQ:KTTA) shares decreased by 13.7% to $0.39. The market value of their outstanding shares is at $8.2 million.
- Monte Rosa Therapeutics (NASDAQ:GLUE) stock declined by 10.43% to $4.47. The company's market cap stands at $223.8 million.
- Assure Hldgs (NASDAQ:IONM) shares declined by 10.0% to $0.37. The market value of their outstanding shares is at $2.4 million. See Also:
This article was generated by Benzinga's automated content engine and reviewed by an editor.